Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)

por Zarrabeitia, Roberto, Fariñas-Álvarez, Concepción, Santibáñez, Miguel, Señaris, Blanca, Fontalba, Ana, Botella, Luisa María, Parra, José Antonio
Publicado 2017

Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1

por Albiñana, Virginia, Zafra, Ma Paz, Colau, Jorge, Zarrabeitia, Roberto, Recio-Poveda, Lucia, Olavarrieta, Leticia, Pérez-Pérez, Julián, Botella, Luisa M.
Publicado 2017

Copy number variations in endoglin locus: mapping of large deletions in Spanish families with hereditary hemorrhagic telangiectasia type 1

por Fontalba, Ana, Fernández-Luna, Jose L, Zarrabeitia, Roberto, Recio-Poveda, Lucia, Albiñana, Virginia, Ojeda-Fernández, Maria L, Bernabéu, Carmelo, Alcaraz, Luis A, Botella, Luisa M
Publicado 2013

Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia

por Buscarini, Elisabetta, Botella, Luisa Maria, Geisthoff, Urban, Kjeldsen, Anette D., Mager, Hans Jurgen, Pagella, Fabio, Suppressa, Patrizia, Zarrabeitia, Roberto, Dupuis-Girod, Sophie, Shovlin, Claire L.
Publicado 2019

Mutation study of Spanish patients with Hereditary Hemorrhagic Telangiectasia

por Fontalba, Ana, Fernandez-L, Africa, García-Alegria, Eva, Albiñana, Virginia, Garrido-Martin, Eva M, Blanco, Francisco J, Zarrabeitia, Roberto, Perez-Molino, Alfonso, Bernabeu-Herrero, Maria E, Ojeda, Maria-Luisa, Fernandez-Luna, Jose L, Bernabeu, Carmelo, Botella, Luisa M
Publicado 2008